SGCG and systemic sclerosis: Significant progress has been achieved in the molecular characterisation of patients with SLE, SS, and SSc based on Type 1 and 2 IFN molecular signatures, peripheral blood immune cell phenotypes, single nucleotide polymorphisms, and methylation status [175,176,177].